Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
EAST: Escitalopram and Effort-Based Decision Making
NCT06696482Phase 2Not yet recruiting
- Sponsor
- University of Oxford
- Start
- Jan 2025
- Primary completion
- Sep 2025
- Modality
- Small Molecules
01
Overview
A Phase 2 trial of Escitalopram oxalate oral solution in apathy, sponsored by University of Oxford. Planned start Jan 2025; status: not yet recruiting.
02
Drugs
Escitalopram oxalate oral solution
03
Conditions
apathy
Beyond the preview
Go deeper on NCT06696482.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT06696482.